Searched for
KOTAK MAHINDRA BANK BLOCK DEAL
Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...- En route to D-Street: NSE files draft papers with SebiThe National Stock Exchange has filed its draft prospectus with Sebi, moving closer to its long-awaited Initial Public Offering. The IPO is...
- HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block dealSepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged...
- Manipal Hospitals is said to plan $1 billion IPO in JulyManipal Health Enterprises is likely to launch its IPO as early as next month, targeting a valuation of around $10 billion. Backed by Temas...
- Positive Breakout: These 11 stocks cross above their 200 DMAsAs long as the stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be an overall uptrend.
- Private banks remain in focus as credit growth strengthens; selectivity key amid valuation concerns: Dnyanada VaidyaPrivate sector banks are attracting investors with robust credit growth and stable asset quality. Experts anticipate a rate cycle shift, bo...
- US-Iran peace deal: Is it enough to end the 2-year drought for Nifty bulls, bring FIIs back?A US-Iran peace framework has sparked a sharp rally in Indian markets, sending crude oil prices lower, strengthening the rupee and promptin...
- NFO Alert: Kotak Mutual Fund launches first SIF with hybrid long-short strategyKotak Mutual Fund has launched its maiden Specialised Investment Fund (SIF), the Kotak Infinity Hybrid Long-Short Fund, marking its entry i...
- Bulls return to banks on RBI's FCNR(B) initiativeTraders are piling into bullish derivative bets on banks, reversing bearish positions, as RBI's foreign currency borrowing measures boost l...
- Uday Kotak questions SpaceX valuation, says only time will tell if we're in ‘mega bubble'Uday Kotak described SpaceX’s blockbuster IPO as a test for capitalism, questioning whether investors are backing humanity’s future or fuel...
- Lenskart block deal; Meesho's kirana pushLenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.
- Banks court wealthy Indian diaspora in $50 billion deposit driveIndian banks are launching a global campaign to attract over $50 billion in deposits from the diaspora. This initiative aims to strengthen ...
- Rupee rallies as oil slump sparks unwinding of dollar longsThe Indian rupee experienced a robust uptick against the dollar on Friday, sparked by newfound optimism regarding peace talks between the U...
- Lenskart shares in focus as Goldman Sachs, Morgan Stanley, others purchase stake in Rs 1,960 crore block dealLenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...
- Goldman Sachs, Morgan Stanley and others buy stake in Rs 1,960 crore Lenskart block dealADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...
- Lenskart Solutions sees Rs 1,862-crore block deal; ADIA likely sellerEyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...
- ADIA to sell 2.3% Lenskart stake in Rs 1,944 crore block dealAbu Dhabi Investment Authority is set to divest a 2.3% stake in Lenskart for approximately Rs 1,944 crore via a block deal. This follows So...
- Why is market rising? Sensex jumps 1,000 points in 2 days, Nifty crosses 23,400. 3 key factors behind the surgeIndian stock markets surged for a second consecutive session, with Sensex and Nifty crossing significant milestones. This resilience occurr...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
